CD36 immunization in a patient undergoing hematopoietic stem cell transplantation

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 660-662

  Culler, Elizabeth E ^a   Hillyer, Christopher D ^a   Haight, Ann E ^a   Castillejo, Marta Inés ^a   Josephson, Cassandra D ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Anti CD36; Anti GPIIIb; Anti GPIV; Hematopoietic stem cell transplantation (HSCT); Platelet refractory

Indexed keywords

CD36 ANTIBODY; CD36 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY SCREENING; APHERESIS; ARTICLE; CASE REPORT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTIGENS, CD36; ANTIGENS, HUMAN PLATELET; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNIZATION; ISOANTIBODIES; MALE; PLATELET TRANSFUSION; TRANSPLANTATION CONDITIONING;

EID: 38549107896     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21180     Document Type: Article

References (19)

1. Lee K, Godeau B, Fromont P, et al. CD36 deficiency is frequent and can cause platelet immunization in Africans. Transfusion 1999;39: 873-879.
2. Fujino H, Ohta K, Taniue J, et al. Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone. Vox Sang 2001;81: 42-44.
3. Ikeda H, Mitani T, Ohnuma M, et al. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 1989;57:213-217.
4. Tomiyama Y, Take H, Ikeda H, et al. Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood 1990;75:684-687.
5. Yamamoto N, Ikeda H, Tandon NN, et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka-platelets lack detectable GPIV (CD36). Blood 1990;76:1698-1703.
6. PAKPLUS package insert. GTI. Waukesha, WL, 2003.
7. Febbraio M, Hajjar DP, Silverstein RL. CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001;108:785-791.
8. Hirano K, Kuwasako T, Nakagawa-Toyama Y, et al. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 2003;13:136-141.
9. Curtis BR, Aster RH. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 1996;36:331-334.
10. Yamamoto N, Akamatsu N, Sakuraba H, et al. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83:392-397.
11. Bierling P, Godeau B, Fromont P, et al. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization. Transfusion 1995;35:777-782.
12. Curtis BR, Ali S, Glazier AM, et al. Isoimmunization against CD36 (glycoprotein IV): Description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion 2002;42:1173-1179.
13. Ogata T, Ohto H, Yasuda H, et al. CD36 (Naka) sensitization with platelet transfusion refractoriness in a liver transplant recipient. Transplantation 2005;79:620.
14. Cannon M, Uhl L, Chang C. Fatal post-transfusion purpura with anti-GPIV. Transfusion 2000;40:107S.
15. Morishita K, Wakamoto S, Miyazaki T, et al. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody. Transfusion 2005;45:803-806.
16. Okajima S, Cho K, Chiba H, et al. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody. Thromb Haemost 2006;95:267-271.
17. Kankirawatana S, Kupatawintu P, Juji T, et al. Neonatal alloimmune thrombocytopenia due to anti-Nak(a). Transfusion 2001;41:375-377.
18. Kashiwagi H, Tomiyama Y, Nozaki S, et al. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: Identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet 2001; 108:459-466.
19. Wakamoto S, Fujihara M, Urushibara N, et al. Heterogeneity of platelet responsiveness to anti-CD36 in plasma associated with adverse transfusion reactions. Vox Sang 2005;88:41-51.